Subscribe to RSS
DOI: 10.1055/s-0042-1759645
Outpatient Foley Catheter for Induction of Labor in Obese Nulliparous Patients: A Secondary Analysis of OFFSITE II Randomized Controlled Trial
Funding None.Abstract
Objective In the OFFSITE II randomized controlled trial, outpatient cervical ripening with a Foley catheter (CF) in nulliparous patients undergoing elective induction of labor (eIOL) shortened the time from admission to delivery. Given that patients with obesity have protracted labor and higher rates of failed IOL, we sought to determine if outpatient ripening with a CF may be even more beneficial for this high-risk group.
Study Design We performed a secondary analysis of the OFFSITE II randomized controlled trial. For this analysis, all patients from the primary trial were classified by their intervention assignment (inpatient vs. outpatient) and also by their admission body mass index (BMI) class (BMI ≥ 30 and BMI < 30 kg/m2). The primary outcome was time from labor and delivery (L&D) admission to delivery. Secondary outcomes included cesarean delivery, time from admission to hospital discharge, and rates of clinically diagnosed chorioamnionitis and endometritis.
Results In patients with BMI ≥ 30, the primary outcome, time from admission to delivery, (18.0 [13.5–20.9] vs. 20.4 [16.6–31.3] hours, p = 0.01), as well as total hospitalization length (3.2 [2.5–3.3] vs. 3.4 [3.1–4.3] days, p = 0.02) were shorter in the outpatient group. There were no differences in rates of chorioamnionitis or endometritis in outpatient compared with inpatient CF. Furthermore, in those with a BMI ≥ 30, the cesarean rate was significantly lower with outpatient CF (19.4% vs. 44.7%, p = 0.03); it was not statistically different in patients with BMI < 30.
Conclusion In this exploratory retrospective secondary analysis of the OFFSITE II randomized control trial, we found that in patients with BMI ≥ 30 undergoing eIOL, outpatient CF was associated with a lower time from L&D admission until delivery. This was also associated with a shorter time of total hospital duration and decreased the rate of cesarean, a benefit not detected in the overall analysis presented in the primary study. In nulliparas undergoing induction of labor, ripening with outpatient cervical Foley may even more significantly reduce labor duration, total hospital duration, and the rate of cesarean in patients with obesity.
Key Points
-
Outpatient CF was associated with a lower time from L&D admission until delivery in obese nulliparas.
-
Outpatient CF was associated with a shorter time of total hospital duration in obese nulliparas.
-
Outpatient CF was associated with a decreased rate of cesarean birth in obese nulliparas.
Note
Abstract presented at the virtual 41st Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (January 25–30, 2021).
Publication History
Received: 02 August 2022
Accepted: 01 November 2022
Article published online:
07 December 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Ausbeck EB, Jauk VC, Xue Y. et al. Outpatient Foley catheter for induction of labor in nulliparous women: a randomized controlled trial. Obstet Gynecol 2020; 136 (03) 597-606
- 2 Hilliard AM, Chauhan SP, Zhao Y, Rankins NC. Effect of obesity on length of labor in nulliparous women. Am J Perinatol 2012; 29 (02) 127-132
- 3 Grobman WA, Rice MM, Reddy UM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
- 4 Eikelder MT, van Baaren GJ, Rengerink KO. et al. Comparing induction of labour with oral misoprostol or Foley catheter at term: cost-effectiveness analysis of a randomised controlled multi-centre non-inferiority trial. BJOG 2018; 125 (03) 375-383
- 5 Son SL, Benson AE, Hayes EH, Subramaniam A, Clark EAS, Einerson BD. Outpatient cervical ripening: a cost-minimization and threshold analysis. Am J Perinatol 2020; 37 (03) 245-251